medigraphic.com

2006, Number 1

<< Back Next >>

Rev Fac Med UNAM 2006; 49 (1)

Cryptorchidism incidence

López-Cruz G, Reyes-Gómez U, Monroy-Márquez E, Uribe-Noya R, Pérez-Madero G

Language: Spanish
References: 27
Page: 15-19
PDF size: 45.90 Kb.


ABSTRACT

Objective: Cryptorchidism incidence in the pediatric population with disability. Material and methods: Prospective observational not randomized research. Carried out in 116 patients of the Infant Rehabilitation Center, from January 1 to 31 december 2003. The analysis was carried out with charts of frequencies, central tendency measures, confidence intervals in 95% and rate by 10,000. Results: 31 cases were found; in 45% the diagnosis was at birth, in 9% at the age of three years and after that age in 46%. The confidence interval in 95% for those diagnosed at birth was of 0.4186 - 0.4813; 58% not received treatment. 38% received pharmacological treatment with human chorionic gonadotropin at a dose not specified 3% received surgical treatment. The rate of cryptorchidism was 2,672.41 by 10,000. Conclusions: A high percentage of patients with disability have cryptorchidism, with deferred treatment, with high risk of malignant testicular cancer. It is indispensable to create a medical culture to improve the prognosis.


REFERENCES

  1. Fonkalsrud EW. Undescended testes. En: Welch KJ, Randolph JG, Ravth MM at al. Pediatric Surgery. Fourth ed. Year book medical publishers, Inc. Chicago. 1986: 793-807.

  2. Kogan S. Cryptorchidism En: Kelalis PP, King LR, Belman AB (edits) Clinical Pediatric Urology, 3th ed. Philadelphia, Pennsylvania; 1992: 1050-80.

  3. Belchi GFJ. Síndrome de escroto vacío. En: Valoria, VJM (editor) Cirugía Pediátrica. Ediciones Díaz Santos. Madrid, España. 1994: 548-51.

  4. Cilento BG, Samir SN, Atala A. Criptorquidia y torsión testicular. En: Altman RP, Stylianos S (directores huéspedes) Trad. Bernardo Rivera Muñoz. Clínicas Pediátricas de Norteamérica. México. Nueva Editorial Interamericana 1993; 6: 1227-44.

  5. Campbell JR. Testículos no descendidos. En: Ashcraft KW, Holder TM (edits) Cirugía Pediátrica 2a ed. México: Editorial Interamericana McGraw-Hill. 1995: 605-11.

  6. Elder JS. Criptorquidia. En: Resnick MI. Clínicas quirúrgicas de Norteamérica. México. 1988; 5: 1065-90.

  7. Ghirri P, Ciulli C, Vuerich M et al. Incident at birth and natural history of 10,730 consecutive male infants. J Endocrinol Invest 2002; 25(8): 709-15.

  8. Mengel W, Hienz HA, Sippe WG, Hecker WCh. Studies on cryptorchidism: A comparison of histological findings in the germinative epithelium before and after the second year of life. J Pediatr Surg 1974; 9(4): 445-50.

  9. Shoshany G, Shofty R, Livne E, Hayari L, Mardechuvitz D. Testicular neovascularization by omentotesticulopexy: A possible adjuvant in the surgical correction of high undescended testes. J Pediat Surg 1996; 31(9): 1229-32.

  10. Zerella JT, McGill LC. Survival of nonpalpable Undescended testicles after orquidopexy. J Pediat Surg 1993; 28(2): 251-3.

  11. Youngson GG, Jones PF. Management of the impalpable testis: Long-term results of the preperitoneal approach. J Pediat Surg 1991; 26(5): 618-20.

  12. Polascik, Thomas J, Chan-tack et al. Reappraisal of the role of human chorionic gonadotropin in the diagnosis and treatment of the non palpable testis: a 10 year experience. J Urol 1996; 156(25): supplem: 804-806.

  13. Fonkalsrud EW. Management of unilateral cryptorchid testicle. En: Grosfeld JL. (edit) Common problems in pediatric surgery. St Louis. Mosby year book; 1991: 51-4.

  14. Secretaría de Salud. Norma Oficial Mexicana NOM-173-SSA1-1998, para la atención integral de personas con discapacidad.

  15. Declaración de la Asamblea de Rehabilitación Internacional Auckland. 1996. (http://paidos.rediris.es//genysi/framlen.htm)

  16. Berkowitz GS, Lapinski RH, Dolgin SE, Gazella JG, Bodian CA, Holzman IR. Prevalence and natural history of Cryptorchidism. Pediatrics 1993; 92(1): 44-9.

  17. Ghirri P, Ciulli C, Vuerich M, Cuttano A, Faraón M, Guerrini L, Spinelli C, Tognetti S, Boldrini A. Incidence at birth and natural history of Cryptorchidism: a study of 10,730, consecutive male infants. J Endocrinol Invest 2002; 25(8): 709-15.

  18. Swerdlow AJ, Higgins CD, Pike MC. Risk of testicular cancer in cohort of boys with cryptorchidism. BMJ 1997; 314: 1507. (http://bmj.com/cgi/content/full/314/7093/1507)

  19. Nair SG, Rajan B. Seminoma arising in cryptorchid testis 25 years after orquidopexy: case report. Am J Clin Oncol 2002; 25(3): 287-8.

  20. Cortes D, Visfeldt J Moller H, Thorup J. Testicular neoplasia in cryptorchid boys at primary surgery: case series. BMJ 1999; 319(7214): 888-9.

  21. Moller H, Cortes D, Engholm G, Thorup J. Risk of testicular cancer with Cryptorchidism and with testicular biopsy: cohort study. BMJ 1998; 317(7160): 729-30.

  22. Lee P, Coughlin MT. Leydig cell function after Cryptorchidism: evidence of the beneficial result of early surgery. J Urol 2002; 167(4): 1824-7.

  23. Vinardi S, Magro P, Manenti M, Lala R, Costantino S, Cortese MG, Canavese F. Testicular function in men treated in childhood for undescended testes. J Pediatr Surg 2001; 36(2): 385-8.

  24. Esposito C, De Lucia A, Palmieri A, Centonze A, Damiano R, Savanelli A, Valerio G, Settimi A. Comparison of five diferent hormonal treatment protocols for children with cryptorchidism. Scand J Urol Nephrol 2003; 37(3): 246-9.

  25. Hadziselimovic F, Herzog B. Treatment with a luteinizing hormone-releasing analogue after successful orchiopexy markedly improves the chance of fertility later in life. J Urol 1997; 158(3 pt 2): 1193-5.

  26. Hjertkvist M, Lackgren G, Ploen L, Bergh A. ¿Does HCG Treatment induce inflammation-like changes in Undescended testes in boys? J Pediatr Surg 1993; 28(2): 254-8.

  27. Moller H, Skakkebaek NE. Risk of testicular cancer in subfertile men: case-control study. BMJ 1999; 318 (7183):559-62.




2020     |     www.medigraphic.com